Garland J. Scott

Garland J. Scott is listed in filings as Director at Day One Biopharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Apr 23, 2026, including 20 public disclosures. Recent filings connect the profile to Day One Biopharmaceuticals, Inc. (DAWN), Enliven Therapeutics, Inc. (ELVN), ALX Oncology Holdings Inc. (ALXO), and Olema Pharmaceuticals, Inc. (OLMA). The current snapshot covers public activity from Jun 14, 2024 to Apr 23, 2026. Reported amounts are shown as $290.7K to $38.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.